Retinoic acid and DFMO induce differentiation and inhibit tumor formation in neuroblastoma
Austin Voydanoff, Ping Zhao, Mary Durston, Giselle Saulnier Sholler. Retinoic acid and DFMO induce differentiation and inhibit tumor formation in neuroblastoma, American Association for Cancer Research (AACR) Annual Meeting, April, 2017, Washington,[...]
The Signature Study: Molecular Analysis of Pediatric Tumors with Establishment of Tumor Models in a Biology Study
Elizabeth VanSickle, Ping Zhao, Deanna Mitchell, Jess Foley, Julie Steinbrecher, Maria Rich, Abhinav Nagulapally, Jeff Bond, Will Hendricks, Giselle Saulnier Sholler. The Signature Study: Molecular Analysis of Pediatric Tumors with Establishment[...]
Cell surface vimentin is a novel marker for CTC detection in neuroblastoma
Izhar S. Batth, ArunSatelli, Heming Li, AbhisekMitra, HyangsoonNoh, Qing H. Meng, Saulnier Sholler G., Shulin Li. Cell surface vimentin is a novel marker for CTC detection in neuroblastoma, American Association for[...]
Maintenance DFMO Increases Survival in High Risk Neuroblastoma
Giselle L. Saulnier Sholler, William Ferguson, Genevieve Bergendahl, Jeffrey P. Bond, William Roberts, Randal K. Wada, Don Eslin, Javier Oesterland, Jessica Foley, Deanna Mitchell, Nehal S. Parikh, Kathleen Neville, Francis[...]
DFMO targets cancer stem cells in neuroblastoma
Avequin T, Zhao P, NagulapallyAB, Bond J, Azizi E, Wicha M, Saulnier Sholler G, DFMO targets cancer stem cells in neuroblastoma. American Association of Cancer Research (AACR) Annual Meeting, 2016. New Orleans, LA
BKM120 promotes apoptosis and suppresses tumor growth in medulloblastoma by targeting the phosphoinositide 3-kinase pathway
Zhao P, Hall J, Voydanoff A, Durston M, VanSickle E, Nagulapally AB, Bond J, Saulnier Sholler G, BKM120 promotes apoptosis and suppresses tumor growth in medulloblastoma by targeting the phosphoinositide 3-kinase[...]
DFMO Maintains Remission and Increases Overall Survival in High Risk Neuroblastoma: Results of a Phase II Prevention Trial
Giselle L. Saulnier Sholler, William Ferguson, Genevieve Bergendahl, Jeffrey P. Bond, William Roberts, Randal K. Wada, Don Eslin, Javier Oesterland, Jessica Foley, Deanna Mitchell, Nehal S. Parikh, Kathleen Neville, Francis[...]
A Phase II Preventative Trial of DFMO in Patients with High Risk Neuroblastoma in Remission Prevents Relapse and Increases Overall Survival
Giselle L. Saulnier Sholler, William Ferguson, Genevieve Bergendahl, Jeffrey P. Bond, William Roberts, Randal K. Wada, Don Eslin, Javier Oesterland, Jessica Foley, Deanna Mitchell, Nehal S. Parikh, Kathleen Neville, Francis[...]
HDAC inhibitor panobinostat as a selective agent, synergizes with chemotherapeutics in medulloblastoma and neuroblastoma
Witte A, Durston M, Zhao P, Nagulapally AB, Bond J, Saulnier Sholler G, HDAC inhibitor panobinostat as a selective agent, synergizes with chemotherapeutics in medulloblastoma and neuroblastoma. American Association of Cancer Research[...]
BKM120 is cytotoxic in neuroblastoma targeting the PI3K pathway
Pomaville M, Zhao P, DeCou S, Nagulapally AB, Bond J, Saulnier Sholler G, BKM120 is cytotoxic in neuroblastoma targeting the PI3K pathway. American Association of Cancer Research (AACR) Annual Meeting, 2016. New Orleans, LA